- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
RPG Life Sciences Limited — Updates, 27-01-2026: Press Release
27-01-2026 | 07:56 pm
27-01-2026 | 07:56 pm
RPG Life Sciences reported Q3 FY26 revenue of Rs. 180.0 Cr, up 4.2% Y-o-Y, with an EBITDA margin of 24.0%. 9M FY26 revenue grew 4.0%. Domestic Formulations outperformed the market, growing 11.8% vs. IPM's 8.2% in 9M FY26.
No comments yet. Be the first to comment!